查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401862

到 2030 年的神經回饋市場預測：按類型、系統、應用、最終用戶和地區進行的全球分析

Neurofeedback Market Forecasts to 2030 - Global Analysis By Type (Electrodes, Amplifiers, Computer Software and Other Products), System, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球神經回饋市場規模將達到 12 億美元，預計到 2030 年將達到 22 億美元，預測期內複合年成長率為 9.3%。

神經回饋（NFB），也稱為神經療法，是一種生物回饋，利用操作訓練透過提供基於大腦活動的即時回饋來促進健康的大腦功能。 EEG（腦電圖儀）通常透過放置在頭皮上的感測器記錄大腦的電活動，並透過視覺或聽覺顯示提供回饋。

根據國家醫學圖書館 2021 年 4 月發布的資料，思覺失調症每年影響超過 150 萬加拿大人。根據世界衛生組織 (WHO) 統計，全球約有 10 億人患有神經病變，其中約 5,000 萬人被診斷出患有癲癇症。

心理健康問題日益增多

神經回饋是針對日益增加的精神疾病而正在研究的治療方法之一。這種類型的療法試圖透過向患者提供有關腦電波模式的即時回饋來控制大腦活動。精神疾病的增加刺激了對替代療法的研究，因為與傳統治療方法相比，它們可能具有更高的成功率和更少的副作用。這個因素正在影響市場的擴大。

缺乏報銷政策

神經回饋療法不僅醫療費用高昂，也讓醫療專業人員不願意治療。缺乏統一的指南和治療環境可能會導致應用上的差異，並損害神經回饋系統在醫療實踐中的聲譽和接受度。缺乏足夠的補償可能會阻礙醫療機構投資神經回饋系統，從而限制產業成長。

技術進步

神經回饋在臨床環境之外的應用潛力越來越大，包括減輕壓力、改善認知功能和提高運動技能。神經回饋的進步使其在臨床環境之外廣泛應用。借助攜帶式且易於使用的設備，您可以在家中進行訓練並獲得專家支援。隨著行業技術的不斷進步和創新產品的推出，市場正在不斷擴大。

神經回饋高成本

高製造和維護成本是由於技術的複雜性，包括感測器、軟體和資料處理工具。神經回饋的採用因其高成本而受到阻礙，特別是在醫療資源有限的低度開發國家。這意味著很大一部分人無法使用這些技術，從而限制了市場的擴張。操作這些系統所需的知識和指導也會增加整體成本。

COVID-19 的影響

由於 COVID-19 的爆發，壓力、焦慮和心理健康問題不斷升級，這可能會導致更多的人尋求神經反饋治療。然而，對於其他人來說，獲得這些治療方法可能會因不確定性或預算限制而受到阻礙。這場流行病奪走了神經反饋研究和開發計劃的資金和注意力。立即管理健康危機成為當務之急。

預計腦血檢測領域在預測期內規模最大

腦血檢測領域預計將成為預測期內最大的領域。神經回饋中的血腦描記術是一種測量大腦血流波動的方法，特別是額葉皮質的血流波動。它與其他治療方法（例如醫學和認知行為療法）相結合，以改善治療結果。神經回饋被認為是治療多種神經和精神疾病的輔助策略。

預期注意力不足過動症細分市場在預測期內複合年成長率最高

預期注意力不足過動症領域在預測期內複合年成長率最高。注意力不足過動症是兒童最常見的神經發育障礙之一。神經反饋療法和設備的普及以及對研究和開發的日益關注正在推動這一領域的成長。此外，對研發的日益關注正在創造高效的神經反饋並推動市場成長。

佔有率最大的地區

由於擁有設備和套件的先進醫療基礎設施，預計北美在預測期內將佔據最大的市場佔有率。先進的醫療基礎設施以及與醫院有密切聯繫的多家醫療設備公司的存在是該市場成長的關鍵驅動力。許多公司選擇在已開發國家尤其美國進行臨床研究，使其成為產業發展的重要組成部分。

複合年成長率最高的地區：

由於政府投資增加了醫療保健基礎設施，預計亞太地區在預測期內將保持最高的複合年成長率。它已被應用於治療疾病，包括焦慮、憂鬱症、過動症和其他神經系統問題。在這些國家，健康人群也越來越有興趣利用神經回饋來改善認知功能。研究機構和科技公司正在研究神經回饋的潛在用途，包括壓力管理、運動表現增強和心理健康治療。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球神經回饋市場：按產品

  • 介紹
  • 電極
  • 放大器
  • 電腦軟體
  • 其他產品

第6章全球神經回饋市場：按系統

  • 介紹
  • 慢皮質電位
  • 頻率/功率
  • 低能量
  • 腦血檢查
  • 即時 Z 分數
  • 解析度電磁斷層掃描
  • 功能性磁振造影
  • 其他系統

第7章全球神經回饋市場：按應用

  • 介紹
  • 焦慮
  • 注意力不足過動症
  • 憂鬱症
  • 失眠
  • 吸毒成癮
  • 思覺失調症
  • 癲癇
  • 疼痛管理
  • 情緒控制
  • 心理健康
  • 其他用途

第8章全球神經回饋市場：依最終用戶分類

  • 介紹
  • 醫院
  • 神經護理診所
  • 門診手術中心
  • 科學研究
  • 培訓機構
  • 其他最終用戶

第9章全球神經回饋市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Emotiv
  • Brainworks
  • Neuro Care Group
  • Mindfield Biosystems Ltd.
  • Narbis
  • Thought Technology Ltd.
  • Brainmaster Technologies, Inc.
  • InteraXon Inc.
  • Mind Media USA Inc.
  • Mitsar Co. Ltd
  • Wearable Sensing
  • Mind Media BV
  • Stens Corporation
  • Myndlift Ltd
  • NeuralScan
Product Code: SMRC24382

According to Stratistics MRC, the Global Neurofeedback Market is accounted for $1.2 billion in 2023 and is expected to reach $2.2 billion by 2030 growing at a CAGR of 9.3% during the forecast period. Neurofeedback (NFB), also known as neurotherapy, is a kind of biofeedback that uses operant training to encourage healthy brain function by providing real-time feedback based on brain activity. Electroencephalography (EEG) usually records electrical activity from the brain using scalp-mounted sensors and provides feedback through visual or auditory displays.

According to data published in April 2021, on National Library of Medicine, stated that schizophrenia affects more than 1.5 million Canadians every year. According to the World Health Organization (WHO), around 1 billion people globally suffer from neurological disorders, with approximately 50 million people being diagnosed with epilepsy alone.

Market Dynamics:

Driver:

Growing number of mental health issues

Neurofeedback is one of the therapeutic modalities that have been investigated as a result of the rising incidence of mental illnesses. This type of therapy works by giving patients immediate feedback on their brainwave patterns in an effort to control brain activity. Because alternative therapies may be more successful than orthodox treatments and have fewer side effects, research into them has been sparked by the growth in mental health disorders. This element is having an impact on the market's expansion.

Restraint:

Lack of reimbursement policies

Neurofeedback therapy is not only more expensive when it comes to reimbursement, but it also deters medical professionals from providing it. The absence of uniform guidelines and treatment settings may result in differences in application, which might damage neurofeedback systems' reputation and acceptance in the medical field. Insufficient compensation might discourage healthcare institutions from investing in neurofeedback systems, which would limit the growth of the industry.

Opportunity:

Technical advancements

The developments have broadened the range of possible uses for neurofeedback outside of clinical settings, including stress reduction, improving cognitive function, and improving athletic performance. This is now more widely available outside of clinical settings because to advancements. Individuals may receive expert assistance while training at home thanks to equipment that are both portable and easy to use. Due of the industry's ongoing technological breakthroughs and the launch of innovative goods, the market is growing.

Threat:

High cost of neurofeedback

The high cost of production and maintenance can be attributed to the complexity of the technology, which includes the sensors, software, and data processing tools. Adoption of neurofeedback is hampered by its expensive cost, especially in underdeveloped nations with constrained healthcare resources. This means that a large fraction of the population cannot use these technologies, which restricts market expansion. The necessary knowledge and instruction to run these systems also raises the overall cost.

COVID-19 Impact:

Stress, anxiety, and mental health problems have escalated because to the COVID-19 epidemic, which may encourage more people to seek out neurofeedback treatments. For other people, nevertheless, access to these therapies may have been hampered by uncertainty and budgetary limitations. The epidemic took funding and focus away from neurofeedback research and development projects. The urgent health crisis management became the top priority.

The hemoencephalographic segment is expected to be the largest during the forecast period

The hemoencephalographic segment is expected to be the largest during the forecast period. A much more recent method for measuring variations in blood flow in the brain, particularly in the frontal cortex, is hemoencephalography in neurofeedback. To improve treatment results, it is combined with other therapeutic approaches such medicine or cognitive-behavioral therapy. It is regarded as an adjunctive strategy for treating a few neurological and psychiatric disorders.

The attention deficit hyperactivity disorder segment is expected to have the highest CAGR during the forecast period

The attention deficit hyperactivity disorder segment is expected to have the highest CAGR during the forecast period. It is among the most prevalent neurodevelopmental problems in kids. The growing prevalence and the increased attention being paid to neurofeedback therapy and device research and development are what are fueling the segment's growth. Moreover, an increasing focus on research and development is producing efficient neurofeedback, which is promoting market growth.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to advanced healthcare infrastructure with devices and kits. The sophisticated healthcare infrastructure and the presence of several medical device companies with strong ties to hospitals are the main drivers of this market's growth. It is crucial factors in the industry's growth since a lot of corporations choose to do clinical research in developed nations, especially the United States.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period due to rising healthcare infrastructure through government investing. It is applied in therapeutic contexts to treat illnesses including anxiety, depression, ADHD, and other neurological issues. In these nations, there is also a rising interest among healthy persons in employing neurofeedback for cognitive advancement. Research organizations and tech firms are investigating its potential uses in stress management, sports performance improvement, and mental health therapy.

Key players in the market:

Some of the key players in Neurofeedback market include Emotiv, Brainworks, Neuro Care Group, Mindfield Biosystems Ltd., Narbis, Thought Technology Ltd., Brainmaster Technologies, Inc., InteraXon Inc., Mind Media USA Inc., Mitsar Co. Ltd, Wearable Sensing, Mind Media B.V, Stens Corporation, Myndlift Ltd and NeuralScan.

Key Developments:

In January 2023, BrainMaster Technologies launched FocusEdu-S, a neurofeedback system for use in schools to improve student learning and behavior. This launch expands BrainMaster's neurofeedback solutions for the education sector.

In September 2022, NeuroCare Group acquired neuroConn, combining two leading German neurofeedback companies. This acquisition strengthens NeuroCare's position in Europe for neurofeedback systems.

In June 2022, Neurofeedback Labs raised $3 million in seed funding to further develop AI-powered neurofeedback training. This investment will support Neurofeedback Labs' growth in digital therapeutics using neurofeedback.

Products Covered:

  • Electrodes
  • Amplifiers
  • Computer Software
  • Other Products

Systems Covered:

  • Slow Cortical Potential
  • Frequency/Power
  • Low-Energy
  • Hemoencephalographic
  • Live Z-Score
  • Low-Resolution Electromagnetic Tomography
  • Functional Magnetic Resonance Imaging
  • Other Systems

Applications Covered:

  • Anxiety
  • Attention Deficit Hyperactivity Disorder
  • Depression
  • Insomnia
  • Drug Addiction
  • Schizophrenia
  • Epilepsy
  • Pain Management
  • Emotional Regulation
  • Mental Fitness
  • Other Applications

End Users Covered:

  • Hospitals
  • Neurocare Clinics
  • Ambulatory Surgical Center
  • Scientific Research
  • Training Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurofeedback Market, By Product

  • 5.1 Introduction
  • 5.2 Electrodes
  • 5.3 Amplifiers
  • 5.4 Computer Software
  • 5.5 Other Products

6 Global Neurofeedback Market, By System

  • 6.1 Introduction
  • 6.2 Slow Cortical Potential
  • 6.3 Frequency/Power
  • 6.4 Low-Energy
  • 6.5 Hemoencephalographic
  • 6.6 Live Z-Score
  • 6.7 Low-Resolution Electromagnetic Tomography
  • 6.8 Functional Magnetic Resonance Imaging
  • 6.9 Other Systems

7 Global Neurofeedback Market, By Application

  • 7.1 Introduction
  • 7.2 Anxiety
  • 7.3 Attention Deficit Hyperactivity Disorder
  • 7.4 Depression
  • 7.5 Insomnia
  • 7.6 Drug Addiction
  • 7.7 Schizophrenia
  • 7.8 Epilepsy
  • 7.9 Pain Management
  • 7.10 Emotional Regulation
  • 7.11 Mental Fitness
  • 7.12 Other Applications

8 Global Neurofeedback Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Neurocare Clinics
  • 8.4 Ambulatory Surgical Center
  • 8.5 Scientific Research
  • 8.6 Training Institutes
  • 8.7 Other End Users

9 Global Neurofeedback Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Emotiv
  • 11.2 Brainworks
  • 11.3 Neuro Care Group
  • 11.4 Mindfield Biosystems Ltd.
  • 11.5 Narbis
  • 11.6 Thought Technology Ltd.
  • 11.7 Brainmaster Technologies, Inc.
  • 11.8 InteraXon Inc.
  • 11.9 Mind Media USA Inc.
  • 11.10 Mitsar Co. Ltd
  • 11.11 Wearable Sensing
  • 11.12 Mind Media B.V
  • 11.13 Stens Corporation
  • 11.14 Myndlift Ltd
  • 11.15 NeuralScan

List of Tables

  • Table 1 Global Neurofeedback Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neurofeedback Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Neurofeedback Market Outlook, By Electrodes (2021-2030) ($MN)
  • Table 4 Global Neurofeedback Market Outlook, By Amplifiers (2021-2030) ($MN)
  • Table 5 Global Neurofeedback Market Outlook, By Computer Software (2021-2030) ($MN)
  • Table 6 Global Neurofeedback Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 7 Global Neurofeedback Market Outlook, By System (2021-2030) ($MN)
  • Table 8 Global Neurofeedback Market Outlook, By Slow Cortical Potential (2021-2030) ($MN)
  • Table 9 Global Neurofeedback Market Outlook, By Frequency/Power (2021-2030) ($MN)
  • Table 10 Global Neurofeedback Market Outlook, By Low-Energy (2021-2030) ($MN)
  • Table 11 Global Neurofeedback Market Outlook, By Hemoencephalographic (2021-2030) ($MN)
  • Table 12 Global Neurofeedback Market Outlook, By Live Z-Score (2021-2030) ($MN)
  • Table 13 Global Neurofeedback Market Outlook, By Low-Resolution Electromagnetic Tomography (2021-2030) ($MN)
  • Table 14 Global Neurofeedback Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 15 Global Neurofeedback Market Outlook, By Other Systems (2021-2030) ($MN)
  • Table 16 Global Neurofeedback Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Neurofeedback Market Outlook, By Anxiety (2021-2030) ($MN)
  • Table 18 Global Neurofeedback Market Outlook, By Attention Deficit Hyperactivity Disorder (2021-2030) ($MN)
  • Table 19 Global Neurofeedback Market Outlook, By Depression (2021-2030) ($MN)
  • Table 20 Global Neurofeedback Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 21 Global Neurofeedback Market Outlook, By Drug Addiction (2021-2030) ($MN)
  • Table 22 Global Neurofeedback Market Outlook, By Schizophrenia (2021-2030) ($MN)
  • Table 23 Global Neurofeedback Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 24 Global Neurofeedback Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 25 Global Neurofeedback Market Outlook, By Emotional Regulation (2021-2030) ($MN)
  • Table 26 Global Neurofeedback Market Outlook, By Mental Fitness (2021-2030) ($MN)
  • Table 27 Global Neurofeedback Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 28 Global Neurofeedback Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Neurofeedback Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 30 Global Neurofeedback Market Outlook, By Neurocare Clinics (2021-2030) ($MN)
  • Table 31 Global Neurofeedback Market Outlook, By Ambulatory Surgical Center (2021-2030) ($MN)
  • Table 32 Global Neurofeedback Market Outlook, By Scientific Research (2021-2030) ($MN)
  • Table 33 Global Neurofeedback Market Outlook, By Training Institutes (2021-2030) ($MN)
  • Table 34 Global Neurofeedback Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.